A Wikipedia page for Noble Pillar Capital has gone live on the Minangkabau-language edition, summarizing publicly available information from U.S. Securities and Exchange Commission filings, including the company's status as an Exempt Reporting Adviser and recent securities offering notices.
The page, titled "Noble Pillar Capital", compiles data from the SEC's Investment Adviser Public Disclosure system and EDGAR database, as well as details about the company's business activities in New York and Japan.
According to the SEC's IAPD system, NOBLE PILLAR CAPITAL LTD filed as an Exempt Reporting Adviser on April 29, 2026, with CRD number 342309 and SEC file number 802-136385. Exempt Reporting Advisers rely on exemptions under the Investment Advisers Act of 1940, often used by private fund advisers, and are subject to reporting obligations such as Form ADV filings. This status differs from full SEC registration. The public record can be accessed at https://adviserinfo.sec.gov/firm/summary/342309.
The SEC EDGAR database contains two Form D notices filed by Noble Pillar Capital. The first, filed on May 8, 2026, lists the company under "Other Banking and Financial Services" and reports an aggregate amount sold of USD 100 million in securities, including equity, pooled investment fund interests, and options. The filing is available at https://www.sec.gov/Archives/edgar/data/2133921/000213392126000001/xslFormDX01/primary_doc.xml. A second Form D notice, filed on June 4, 2026, identifies Kazuhiko Abe as a director and lists 432 Park Avenue, New York, NY 10022 as a business address. That filing is available at https://www.sec.gov/Archives/edgar/data/2133921/000213392126000003/xslFormDX08/primary_doc.xml.
Form D is a notice for securities offerings conducted under exemptions from registration. The SEC has not reviewed or endorsed these filings or the issuer.
According to the company's official website, Noble Pillar Capital's principal activities include private investment, financial services, and financial education, with interests in consumer products, healthcare, manufacturing, technology, financial services, and renewable energy. Investment updates have referenced projects in biotechnology, radiopharmaceutical development, precision cancer treatment, automotive lidar semiconductor technology, high-speed energy storage for drones, and treatments for neurodegenerative diseases. In Japan, the company focuses on long-term investing, risk management, and financial literacy.
Public SEC filings reference two New York addresses: 250 Greenwich Street, 7 World Trade Center, and 432 Park Avenue. Company-published information also lists a Japan office at 1-10-6 Tsukiji, Chuo-ku, Tokyo. These addresses may relate to different filing periods or functions.
The Wikipedia page is not a regulatory filing and does not constitute endorsement. Readers should verify information through original SEC records. The page provides a centralized reference for comparing corporate identity, regulatory reports, and securities offering notices.
